Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (391-400 of 461) with videos related to

Pageof 47
Sort By:
European Journal of Heart Failure|April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK BiobankTripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
European Journal of Heart Failure|March 26, 2024
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohortMasatake Kobayashi, João Pedro Ferreira, Kevin Duarte, et al.
ESC Heart Failure|March 14, 2020
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failureMasatake Kobayashi, Susan Stienen, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|April 4, 2020
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainscak, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure|February 24, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trialJoão Pedro Ferreira, Job A J Verdonschot, Nicolas Girerd, et al.
ESC Heart Failure|April 12, 2020
Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers studyEiichi Akiyama, Raphaël Cinotti, Kamilė Čerlinskaitė, et al.
Fundamental & Clinical Pharmacology|April 20, 2021
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature reviewNathalie Gault, Marina Esposito-Farèse, Matthieu Revest, et al.
ESC Heart Failure|July 8, 2022
Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantationGuillaume Baudry, Guillaume Coutance, Richard Dorent, et al.
Plos Medicine|April 20, 2022
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocolMarina Wainstein, Samual MacDonald, Daniel Fryer, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Pageof 47

Showing results (391-400 of 461) with videos related to

Sort By:
Pageof 47
European Journal of Heart Failure|April 2, 2022
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK BiobankTripti Rastogi, Frederick K Ho, Patrick Rossignol, et al.
European Journal of Heart Failure|March 26, 2024
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohortMasatake Kobayashi, João Pedro Ferreira, Kevin Duarte, et al.
ESC Heart Failure|March 14, 2020
Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failureMasatake Kobayashi, Susan Stienen, Jozine M Ter Maaten, et al.
European Journal of Heart Failure|April 4, 2020
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainscak, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure|February 24, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trialJoão Pedro Ferreira, Job A J Verdonschot, Nicolas Girerd, et al.
ESC Heart Failure|April 12, 2020
Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers studyEiichi Akiyama, Raphaël Cinotti, Kamilė Čerlinskaitė, et al.
Fundamental & Clinical Pharmacology|April 20, 2021
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature reviewNathalie Gault, Marina Esposito-Farèse, Matthieu Revest, et al.
ESC Heart Failure|July 8, 2022
Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantationGuillaume Baudry, Guillaume Coutance, Richard Dorent, et al.
Plos Medicine|April 20, 2022
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocolMarina Wainstein, Samual MacDonald, Daniel Fryer, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Pageof 47